Pamela Stephenson Gemini Therapeutics, Inc. (GMTX) insider trading activity

Pamela Stephenson is Chief Commercial Officer of Gemini Therapeutics, Inc. . Currently has a direct ownership of 69,529 shares of GMTX, which is worth approximately $1.69 Million. The most recent transaction as insider was on Feb 18, 2025, when has been sold 3,137 shares (Common Stock) at a price of $54.58 per share, resulting in proceeds of $171,217. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 69.5K

89.63% 3M change

89.63% 12M change

Total Value Held $1.69 Million

Pamela Stephenson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 18 2025	SELL Open market or private sale	$171,217 $54.58 p/Share	3,137 Reduced 4.32%	69,529 Common Stock
Feb 10 2025	BUY Grant, award, or other acquisition	-	36,000 Added 33.13%	72,666 Common Stock
Feb 26 2024	BUY Grant, award, or other acquisition	-	36,666 Added 50.0%	36,666 Common Stock

Also insider at

ALBO

ALBIREO PHARMA, INC. Healthcare

Chief Commercial Officer

ZYNE

Zynerba Pharmaceuticals, Inc. Healthcare